April 14, 2021
PAR-21-203 - Limited Competition: Clinical and Translational Science Award (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Not Allowed)
National Center for Advancing Translational Sciences (NCATS)
The purpose of this Notice is to inform applicants of the topic areas for the June 21, 2021 due date of the NCATS CTSA Program funding opportunity announcement (FOA) PAR-21-203, “Limited Competition: Clinical and Translational Science Award (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Not Allowed)”.
Through this notice, NCATS will support applications for Clinical and Translational Science Award (CTSA) Program consortium-wide resource centers that will rapidly demonstrate and disseminate innovative resources (to include capabilities) that have demonstrated impact at a local or national level to the wider consortium. Applicants must address one but not both of the topics below.
Health Informatics: Solutions to enhance clinical research, including the ability to collect and analyze large data sets and implement innovative informatics solutions that improve human health.
It is expected that all projects will promote Open Science (FAIR) Data Sharing; Privacy and Security Standards; Attribution, Reproductivity, Transparency, Generalizability, and Best Practices; and Enterprise Maturity Standards for next generation clinical research.
Demonstrating Research Impact: Leveraging innovative approaches to assess, quantify, and communicate research impact for large networks.
Applications that do not address one of the two research areas stated above will be considered non-responsive to the NOSI and withdrawn without review.
Application and Submission Information
This notice applies to the June 21, 2021 due date for the following FOA:
All instructions in the SF424 (R&R) Application Guide and the funding opportunity announcement used for submission must be followed, with the following additions:
Applications nonresponsive to terms of this NOSI will not be considered for the NOSI initiative.